Indiana University (123) — Indianapolis, Indiana

Indiana University (123) is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana University (123) has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor, Adult.

Sponsors: Immune-Onc Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University (123)?

Indiana University (123) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University (123) conducted?

Indiana University (123) has 1 clinical trials on record. Their work covers Solid Tumor, Adult.

Is Indiana University (123) accredited by Crixeo Health?

Indiana University (123) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University (123)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.